{
    "title": "110_hr4083",
    "content": "The Act titled \"Non-Prescription Drug Modernization Act of 2007\" amends or repeals monographs in the Federal Food, Drug, and Cosmetic Act. The Act \"Non-Prescription Drug Modernization Act of 2007\" allows for amendments or repeals of drug monographs without the need for notice and public procedure if there is a significant risk associated with the drug as determined by the Secretary of Health and Human Services. The Act allows for amendments or repeals of drug monographs without notice if there is a significant risk associated with the drug, based on evidence of effectiveness. After the change, a comment period may be provided for public input. Expansion of FDA's authority to regulate drug advertising. The Federal Food, Drug, and Cosmetic Act is amended to include regulations regarding approved drug applications and drug marketing. The Commissioner of Food and Drugs is responsible for enforcing these regulations. The Commissioner of Food and Drugs will revise regulations under the Federal Food, Drug, and Cosmetic Act to implement the amendments. During the transition period, any false or misleading advertisements for non-prescription drugs are considered misbranded. Definitions for terms used in this subsection are provided. The terms in this subsection have meanings as defined in section 502(n) of the Federal Food, Drug, and Cosmetic Act. SEC. 4. IDENTIFICATION AND REPORT ON MONOGRAPHS. The Commissioner of Food and Drugs will identify monographs that may need review for amendment or repeal, with input from interested parties. A report will be submitted to Congress within 2 years to identify monographs needing further review. The Commissioner of Food and Drugs will identify monographs for review to determine if they need amendment or repeal. A report to Congress will include an assessment of resources needed, a summary of received comments, and a list of monographs recommended for amendment or repeal with the basis for the recommendations. Authorization of appropriations is granted to carry out the Act and its amendments."
}